CMI CommunicationsUnclaimed
Host of Communicable.
1 Feed-stated
Counts Verified and Feed-stated credits: what a show's own feed states, or a confirmation backs. See the record
- Host
Claim this profile Add a creditIs this you? Claiming needs a free account. You sign in or join, then come straight back here.
This profile is unclaimed. PodSubs built it from public show feeds and credits. The person it is about has not reviewed it yet.
PodCred record
PodCred is the verified record of where CMI has worked and appeared. These credits come from the shows' own feeds and wait for people who were there to confirm them.
Worked with CMI on a show? This is where you give them credit.
Shows they work on now
1 show
Is an appearance missing?
People get invited back because someone remembered they were great. If you heard this person on a show and it is not listed here, add it. Your memory might be the reason they get their next invitation.
No account needed. Anyone can give a credit.
Experience, education, skills, and recommendations start empty. They fill in when CMI claims this profile.
Recommendations
No recommendations for CMI yet.
Recommendations open once CMI claims the profile.
Posts
No posts yet. Posts CMI shares on PodSubs, and what CMI publishes on Substack, YouTube and elsewhere, will show here.
Recent episodes
From the shows they work on now
Communicable E67: New antifungals & how to use them
In this episode of Communicable, hosts Annie Joseph and Josh Nosanchuk welcome Neil Stone and Jeniel Nett to discuss new and emerging antifungal treatments, including ibrexafungerp, rezafungin and olorofim, among...
Communicable E66: Diagnostics in the AMR era
Ahead of World Antimicrobial Resistance Awareness Week (WAAW), Communicable presents a special episode exploring the role of diagnostics within the space of antimicrobial resistance (AMR). Hosts Thomas Tängdén and Annie...
Communicable E65: Quarterly catch-up (October 2026 edition)
In this episode of Communicable, Emily McDonald returns for another ‘Quarterly catch-up’ and is joined by Angela Huttner as co-host. Together, they review four recent randomised clinical trials, focusing on antibiotic...
Communicable E64: Getting micro on macrolides for community-acquired pneumonia
In this episode of Communicable, hosts Emily McDonald and Marc Bonten are joined by Sylvain Lother and Valentijn Schweitzer for a discussion on the use of macrolides in community-acquired pneumonia. Together, they...
Communicable E63: Does oseltamivir harm critically ill patients? The REMAP-CAP results
At the Critical Care Reviews meeting in Belfast in June this year, REMAP-CAP investigators presented results suggesting that oseltamivir may be harmful in critically ill patients with influenza, upending a long-standing...
Communicable E62: The 'prose' and cons of the POET trial – early oral antibiotic switch for endocarditis
In this episode of Communicable, Emily McDonald and Josh Davis host Henning Bundgaard and Sami El-Dalati for a discussion on early oral antibiotic switch for endocarditis, focusing on the POET trial, led by Bundgaard,...
Communicable E61: We will make you love PK/PD, part 3
In this episode of Communicable, Amy Legg (Brisbane, Australia), Rekha Pai Mangalore (Melbourne, Australia) & Angela Huttner (Geneva, Switzerland) return for the third part of the ‘We will make you love PK/PD’ series....
Communicable E60: Quarterly catch-up (August 2026 edition)
In the second edition of 'Quarterly catch-up', CMI Communications editors Emily McDonald and Erin McCreary round-up the biggest news in infectious diseases and review clinical microbiology and infectious diseases...
Communicable E59: 'Ask me anything' – EUCAST and CLSI leadership explain
In this episode of Communicable, Nav Narayanan and Thomas Tängdén kick off the first 'Ask me anything' episode, inviting EUCAST and CLSI leadership Sören Gatermann, Christian Giske and Amy Mathers to answer questions...
Communicable E58: Reducing hospital-acquired pneumonia – the HAPPEN trial and how it happened
In this episode of Communicable, Angela Huttner and Josh Davis are joined by Brett Mitchell, Aline Wolfensberger and Lauren Clack to discuss the HAPPEN trial to prevent hospital-acquired pneumonia led by Mitchell--and...
